Cargando…
miR579-3p is an inhibitory modulator of neointimal hyperplasia and transcription factors c-MYB and KLF4
Neointimal hyperplasia (IH) is a common vascular pathology that typically manifests in in-stent restenosis and bypass vein graft failure. Smooth muscle cell (SMC) phenotypic switching is central to IH, both regulated by some microRNAs, yet the role of miR579-3p, a scarcely studied microRNA, is not k...
Autores principales: | Xie, Xiujie, Shirasu, Takuro, Li, Jing, Guo, Lian-Wang, Kent, K. Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946956/ https://www.ncbi.nlm.nih.gov/pubmed/36813774 http://dx.doi.org/10.1038/s41420-023-01364-7 |
Ejemplares similares
-
Smad2 inhibition of MET transcription potentiates human vascular smooth muscle cell apoptosis
por: Xie, Xiujie, et al.
Publicado: (2021) -
Restoring the Platelet miR-223 by Calpain Inhibition Alleviates the Neointimal Hyperplasia in Diabetes
por: Su, Meiling, et al.
Publicado: (2020) -
The Role of MicroRNA-21 in Venous Neointimal Hyperplasia: Implications for Targeting miR-21 for VNH Treatment
por: Kilari, Sreenivasulu, et al.
Publicado: (2019) -
miR548ai antagonism attenuates exosome-induced endothelial cell dysfunction
por: Xie, Xiujie, et al.
Publicado: (2021) -
Exosomes from mesenchymal stem cells expressing miR‐125b inhibit neointimal hyperplasia via myosin IE
por: Wang, Dongqing, et al.
Publicado: (2018)